GMP
-
HLB Group Acquires ANYGEN to Expand Peptide-Based TherapeuticsBig Tech 2025. 3. 11. 02:22
· Strategic acquisition secures key GMP-certified manufacturing, fuels GLP-1 innovation and oncology advancements. SEOUL, South Korea, March 10, 2025 (IT Times) – HLB Group has announced its acquisition of ANYGEN, a South Korean biotechnology company boasting the nation's only GMP-certified peptide manufacturing facility. This strategic move positions HLB Group to capitalize on the burgeoning ma..
-
입셀, 식약처 '인체세포등 관리업' 허가 취득Big Tech 2024. 8. 27. 15:11
· 유도만능줄기세포 기반의약품 개발 가속화 · CMO∙CDMO 사업 확대 통한 기업 성장 기대https://www.ittimes.com/news/articleView.html?idxno=46238 입셀, 식약처 '인체세포등 관리업' 허가 취득 - IT타임스유도만능줄기세포(iPSC) 전문 기업 입셀(YiPSCELL)은 식품의약품안전처로부터 '인체세포등 관리업' 허가를 취득했다고 27일 밝혔다.첨단재생의료 및 첨단바이오의약품 안전 및 지원에 관한 법률(이www.ittimes.com